Supernus Pharmaceuticals
SUPN
SUPN
223 hedge funds and large institutions have $1.42B invested in Supernus Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 83 increasing their positions, 83 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
223
Holders Change
-5
Holders Change %
-2.19%
% of All Funds
3.77%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
27
Increased
83
Reduced
83
Closed
27
Calls
$1.54M
Puts
$2.36M
Net Calls
-$818K
Net Calls Change
-$2.19M
Top Buyers
| 1 |
1
Millennium Management
New York
|
$7.06M |
| 2 |
2
Morgan Stanley
New York
|
$13.7M |
| 3 |
LCG
3
Lisanti Capital Growth
New York
|
$12.1M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$7.32M |
| 5 |
5
Renaissance Technologies
New York
|
$40.4M |
